S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:SGEN

Seagen Stock Competitors

$139.64
-2.99 (-2.10%)
(As of 05/20/2022 04:00 PM ET)
Add
Compare
Today's Range
$136.11
$144.46
50-Day Range
$108.81
$156.12
52-Week Range
$105.43
$192.79
Volume
1.69 million shs
Average Volume
1.33 million shs
Market Capitalization
$25.70 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.85

Seagen (NASDAQ:SGEN) Vs. AMGN, GILD, REGN, VRTX, BIIB, INCY, ALNY, BMRN, EXAS, and UTHR

Should you be buying Seagen stock or one of its competitors? The main competitors of Seagen include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Exact Sciences (EXAS), and United Therapeutics (UTHR). These companies are all part of the "biotechnology" industry.

Seagen vs.

Seagen (NASDAQ:SGEN) and Amgen (NASDAQ:AMGN) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk, community ranking and dividends.

Amgen has a net margin of 21.75% compared to Seagen's net margin of -41.32%. Amgen's return on equity of 165.95% beat Seagen's return on equity.

Company Net Margins Return on Equity Return on Assets
Seagen -41.32% -21.86% -18.07%
Amgen 21.75% 165.95% 16.30%

90.4% of Seagen shares are held by institutional investors. Comparatively, 79.0% of Amgen shares are held by institutional investors. 27.3% of Seagen shares are held by insiders. Comparatively, 0.5% of Amgen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Seagen has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, Amgen has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500.

Amgen received 744 more outperform votes than Seagen when rated by MarketBeat users. Likewise, 73.96% of users gave Amgen an outperform vote while only 66.45% of users gave Seagen an outperform vote.

CompanyUnderperformOutperform
SeagenOutperform Votes
719
66.45%
Underperform Votes
363
33.55%
AmgenOutperform Votes
1463
73.96%
Underperform Votes
515
26.04%

Seagen currently has a consensus target price of $160.00, suggesting a potential upside of 14.58%. Amgen has a consensus target price of $239.36, suggesting a potential downside of 3.29%. Given Seagen's stronger consensus rating and higher possible upside, equities research analysts plainly believe Seagen is more favorable than Amgen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Seagen
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
Amgen
1 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.14

Amgen has higher revenue and earnings than Seagen. Seagen is trading at a lower price-to-earnings ratio than Amgen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Seagen$1.57 billion16.33-$674.47 million-$3.77-37.04
Amgen$25.98 billion5.09$5.89 billion$10.1624.36

In the previous week, Amgen had 1 more articles in the media than Seagen. MarketBeat recorded 9 mentions for Amgen and 8 mentions for Seagen. Amgen's average media sentiment score of 0.33 beat Seagen's score of -0.35 indicating that Amgen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Seagen
1 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
Amgen
1 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Amgen beats Seagen on 11 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

Seagen (NASDAQ:SGEN) vs. Its Competitors

MetricSeagenBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$26.25B$2.61B$4.32B$5.71B
Dividend YieldN/A2.26%2.02%3.19%
P/E Ratio-37.042.908.7310.96
Price / Sales16.33217.502,413.07102.30
Price / CashN/A16.5622.9283.75
Price / Book8.574.074.034.63
Net Income-$674.47M$102.32M$164.30M$240.07M
7 Day Performance2.96%1.25%1.08%0.27%
1 Month Performance-1.27%-15.90%-14.07%-11.21%
1 Year Performance-8.93%-41.80%-31.01%-26.98%

Seagen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMGN
Amgen
2.6174 of 5 stars
$247.50
+1.1%
$239.36
-3.3%
-1.8%$130.76B$25.98B24.3624,200
GILD
Gilead Sciences
3.0524 of 5 stars
$63.84
+0.9%
$72.71
+13.9%
-7.9%$79.36B$27.31B17.8314,400
REGN
Regeneron Pharmaceuticals
2.0878 of 5 stars
$661.14
+0.6%
$726.33
+9.9%
+28.8%$71.33B$16.07B9.3610,368
VRTX
Vertex Pharmaceuticals
2.075 of 5 stars
$258.59
+1.2%
$272.95
+5.6%
+19.4%$66.14B$7.57B27.223,900Short Interest ↓
BIIB
Biogen
2.2948 of 5 stars
$199.65
+3.4%
$275.47
+38.0%
-30.3%$28.28B$10.98B20.449,610
INCY
Incyte
2.9083 of 5 stars
$74.88
+0.7%
$87.09
+16.3%
-10.3%$16.59B$2.99B17.832,094Short Interest ↑
ALNY
Alnylam Pharmaceuticals
2.5074 of 5 stars
$132.27
+2.2%
$219.76
+66.1%
-5.6%$15.63B$844.29M-17.661,665
BMRN
BioMarin Pharmaceutical
2.7596 of 5 stars
$79.72
+0.6%
$114.31
+43.4%
+0.8%$14.67B$1.85B442.893,045
EXAS
Exact Sciences
2.5068 of 5 stars
$53.17
-1.5%
$106.00
+99.4%
-49.7%$9.50B$1.77B-12.316,500
UTHR
United Therapeutics
2.1998 of 5 stars
$188.33
+1.1%
$233.40
+23.9%
-1.4%$8.53B$1.69B13.03965Insider Selling
RGEN
Repligen
2.5081 of 5 stars
$154.53
-0.1%
$301.50
+95.1%
-14.8%$8.42B$670.53M61.081,852Short Interest ↑
NBIX
Neurocrine Biosciences
2.7221 of 5 stars
$86.18
+0.9%
$112.21
+30.2%
-8.7%$8.16B$1.13B119.69900
HALO
Halozyme Therapeutics
2.1414 of 5 stars
$44.32
+1.1%
$50.50
+13.9%
+3.8%$6.11B$443.31M14.82145
EXEL
Exelixis
2.7581 of 5 stars
$17.76
+1.8%
$32.29
+81.8%
-27.0%$5.70B$1.43B19.30954Analyst Downgrade
IONS
Ionis Pharmaceuticals
1.664 of 5 stars
$39.49
+0.9%
$41.88
+6.0%
+8.0%$5.60B$810M-197.44660
ALKS
Alkermes
1.682 of 5 stars
$30.00
+1.8%
$30.67
+2.2%
+36.9%$4.82B$1.17B-78.952,211
NVAX
Novavax
1.9833 of 5 stars
$53.42
-8.6%
$186.50
+249.1%
-63.5%$4.57B$1.15B-3.021,541Analyst Report
Gap Down
FOLD
Amicus Therapeutics
1.9336 of 5 stars
$7.76
+4.6%
$15.14
+95.1%
-15.2%$2.17B$305.51M-8.00496
OPK
OPKO Health
2.3648 of 5 stars
$3.09
+3.3%
$6.00
+94.2%
-16.3%$2.04B$1.77B-17.175,767Insider Buying
Gap Up
EBS
Emergent BioSolutions
2.4314 of 5 stars
$35.33
+11.5%
$49.17
+39.2%
-39.8%$1.77B$1.79B12.142,416Gap Up
High Trading Volume
IRWD
Ironwood Pharmaceuticals
2.4248 of 5 stars
$11.39
-0.6%
$15.00
+31.7%
-8.4%$1.75B$413.75M3.57219
MYGN
Myriad Genetics
1.9115 of 5 stars
$21.97
+2.0%
$29.00
+32.0%
-19.7%$1.73B$690.60M-183.082,400
BCRX
BioCryst Pharmaceuticals
2.3548 of 5 stars
$9.10
+0.8%
$18.36
+101.8%
-34.9%$1.69B$157.17M-8.50358
CCXI
ChemoCentryx
2.0914 of 5 stars
$22.79
+3.4%
$75.00
+229.1%
+126.5%$1.57B$32.22M-11.34178
DVAX
Dynavax Technologies
2.0464 of 5 stars
$10.80
-3.4%
$23.50
+117.6%
+37.9%$1.41B$439.44M19.64311
LGND
Ligand Pharmaceuticals
2.8681 of 5 stars
$82.88
+0.2%
$180.83
+118.2%
-32.9%$1.40B$277.13M60.06154Analyst Upgrade
CLDX
Celldex Therapeutics
2.0333 of 5 stars
$29.16
+0.8%
$65.00
+122.9%
+5.5%$1.36B$4.65M-17.05132News Coverage
MDGL
Madrigal Pharmaceuticals
2.4514 of 5 stars
$66.71
-1.7%
$167.43
+151.0%
-48.6%$1.14BN/A-4.5571
INVA
Innoviva
1.5815 of 5 stars
$16.29
+2.4%
$13.00
-20.2%
+22.3%$1.11B$391.87M7.615
MNKD
MannKind
2.1248 of 5 stars
$3.68
+4.8%
$6.00
+63.0%
-14.6%$929.46M$75.44M-9.95348
IMGN
ImmunoGen
1.9615 of 5 stars
$3.58
+1.4%
$10.25
+186.3%
-44.1%$778.49M$69.86M-5.97106Gap Up
CDXS
Codexis
1.8714 of 5 stars
$10.49
+0.2%
$34.20
+226.0%
-46.6%$685.00M$104.75M-31.79261Gap Up
SGMO
Sangamo Therapeutics
1.8214 of 5 stars
$4.14
+3.5%
$15.00
+262.3%
-62.2%$586.75M$110.70M-3.39431High Trading Volume
VNDA
Vanda Pharmaceuticals
2.1814 of 5 stars
$9.92
+0.3%
$12.00
+21.0%
-46.5%$560.38M$268.68M31.00278
ICPT
Intercept Pharmaceuticals
2.4224 of 5 stars
$17.46
+1.7%
$28.33
+62.3%
+1.1%$509.88M$363.47M-7.76437
GERN
Geron
1.7998 of 5 stars
$1.33
+0.8%
$5.50
+313.5%
-8.3%$498.23M$1.39M-3.6969Gap Up
AGEN
Agenus
2.0914 of 5 stars
$1.57
+1.9%
$11.00
+600.6%
-62.4%$425.45M$295.67M-15.70441
RIGL
Rigel Pharmaceuticals
2.0581 of 5 stars
$2.01
-5.2%
$7.67
+281.4%
-45.4%$364.75M$149.24M-4.10165
LXRX
Lexicon Pharmaceuticals
1.9131 of 5 stars
$1.77
+6.0%
$20.00
+1,029.9%
-59.3%$249.82M$300K-2.8587News Coverage
Positive News
Gap Up
VSTM
Verastem
2.2314 of 5 stars
$1.25
+1.6%
$6.00
+380.0%
-60.8%$232.95M$2.05M-3.0548Analyst Upgrade
Short Interest ↑
News Coverage
Gap Up
XOMA
XOMA
2.1714 of 5 stars
$18.35
+1.5%
$49.00
+167.0%
-41.4%$206.38M$38.16M34.6212
AVEO
AVEO Pharmaceuticals
1.8981 of 5 stars
$4.01
-3.6%
$18.50
+361.3%
-42.4%$138.27M$42.29M-3.31114
SPPI
Spectrum Pharmaceuticals
2.0848 of 5 stars
$0.74
flat
$4.00
+438.4%
-78.2%$133.39MN/A-0.84163Positive News
CLVS
Clovis Oncology
1.7981 of 5 stars
$0.71
flat
$4.88
+583.7%
-86.5%$102.63M$148.76M-0.34N/AGap Up
FBIO
Fortress Biotech
2.1898 of 5 stars
$0.89
-3.4%
$11.00
+1,138.3%
-76.5%$95.41M$68.79M-1.03173Analyst Upgrade
News Coverage
Gap Up
SABS
SAB Biotherapeutics
1.5265 of 5 stars
1.92
-5.9%
17.00
+785.4%
N/A$87.64M$60.88M0.00139
CRIS
Curis
2.1648 of 5 stars
$0.79
-0.3%
$12.25
+1,446.7%
-94.6%$72.58M$10.65M-1.3960Gap Up
MACK
Merrimack Pharmaceuticals
1.7931 of 5 stars
$5.25
flat
N/A-18.6%$70.40MN/A-37.50426Analyst Report
News Coverage
ACHV
Achieve Life Sciences
1.7581 of 5 stars
$6.90
-2.8%
$24.25
+251.4%
-25.7%$68.74MN/A-1.8216Positive News
BOLT
Bolt Biotherapeutics
2.1648 of 5 stars
$1.63
-1.8%
$24.00
+1,372.4%
-91.3%$61.08M$1.26M-0.6291Analyst Report
Analyst Revision
News Coverage
Gap Up
This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.